MALE PREVENTION. WHAT’S THE PSA (PROSTATE SPECIFIC ANTIGEN) TEST FOR?

/

The PSA (Prostate specific antigen) is a protein produced by the prostate cells and is present in small quantities in blood. The test is carried out to investigate a possible thickening of prostate and then the presence of a possible gland disease as a cancer.

The prostate control must be carried out periodically by an urologist who, during the visit, reconstructs the clinical history of patient and examines the dimension and consistency of gland through a rectal exploration and, if necessary, prescribes the PSA dosage test.

The prostate problems could occur at any age as the prostatites that affect even the young people from the age of 20. The hypertrophy, thickening or cancer of prostate has a higher incidence from the age of 50.

It is clear that for those who have familiarity with the carcinoma of the prostate the prevention and so the PSA test must be carried out once a year and it is recommended from the age of 40, indeed, in absence of familiarity it is correct to conduct a control investigation of prostate every two years from the age of 50.

The Clinica San Francesco reaches 1000 robotic hip replacements

/

The Clinica San Francesco consolidates its primacy in the field of robotic surgery.

In October 2020 MD Piergiuseppe Perazzini, Director of Orthopaedics and Traumatology Functional Unit, and his staff reached the number of 1000 hip replacements carried out with robotic procedure. Dr Perazzini is the European pioneer of this procedure, having introduced it first in Europe (and second one worldwide after USA) in December 2012, and currently in Italy he has got the highest number of hip replacement operations (further the knee ones) with the Mako robot. Dr Perazzini had learned and acquired the innovative method at the Robotic Surgery Center of Mako firm in Fort Lauderdale, and at the orthopaedic clinic – directed by MD Jon Dounchis, in Naples, both in Florida (USA).

The procedure minimizes the error margin in the prosthesis placement, main cause of instability and dislocations with frequent need of re-operation. This allows to achieve a high surgery precision, permitting a correct biomechanical working of implant. The expertise and long experience of Dr Perazzini made him the top expert of the field to which the Italian and European colleagues address to learn in detail the robotic procedure through technical laboratories, live surgery and lectures.

This allowed the Clinic to become in 2013 CORE (European Robotic Orthopaedic Centre) and in 2019 was recognized by the Veneto Region as reference facility for the robotic orthopaedic surgery.